Plain-English translation of NCT04368702 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new way to deliver radiation therapy for cancer using live MRI imaging. Instead of planning radiation treatment once before therapy begins, doctors will use MRI scans during each radiation session to see exactly where the cancer is and adjust the radiation beam in real time. This approach aims to hit cancer more accurately while sparing healthy tissue.
Standard radiation therapy is planned before treatment starts, but tumors can shift slightly between sessions or during treatment. This study explores whether real-time imaging during radiation could help doctors adapt treatment on the spot, potentially improving results and reducing side effects.
You likely qualify if…
You likely don't qualify if…
You will come to the hospital for screening to confirm you qualify for the study. If accepted, you will receive radiation therapy guided by MRI imaging — meaning doctors will take MRI pictures during your treatment sessions to help them target the radiation more precisely. Throughout the study, you'll have follow-up visits to check how you're doing, and you'll complete some questionnaires about your experience. The study team will monitor your safety and recovery.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States
Sponsor
Brigham and Women's Hospital
Enrollment target
~70 participants
Started
May 2021
Primary completion
June 2029
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Raymond Mak, MD
Dana-Farber Cancer Institute
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.